XBiotech Inc. (XBIT) Form 8-K Material Events
XBiotech Inc. (XBIT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: XBIT
CIK: 1626878
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: A1
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Whitley Penn LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerBrett Murphy
Audit LocationAustin, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| ARS | 2026-10-02 | 2026-10-02 | ARS | 0001171843-26-006363 | View SEC Doc Filr Page |
| DEF 14A | 2026-10-02 | 2026-11-24 | FORM DEF 14A | 0001171843-26-006362 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | FORM 10-Q | 0001171843-26-005492 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | FORM 10-Q | 0001171843-26-003419 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-29 | 2025-12-31 | FORM 10-K/A | 0001171843-26-002814 | View SEC Doc Filr Page |
| 10-K | 2026-03-13 | 2025-12-31 | FORM 10-K | 0001171843-26-001561 | View SEC Doc Filr Page |
| S-8 | 2026-03-11 | — | FORM S-8 | 0001171843-26-001492 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-01-23 | — | SCHEDULE 13G/A Filing | 0001171843-26-000406 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-01-23 | — | SCHEDULE 13G/A Filing | 0001171843-26-000403 | View SEC Doc Filr Page |
| 8-K | 2025-12-09 | 2025-12-05 | FORM 8-K | 0001171843-25-007836 | View SEC Doc Filr Page |
| 10-Q | 2025-11-12 | 2025-09-30 | FORM 10-Q | 0001171843-25-007233 | View SEC Doc Filr Page |
| 4 | 2025-11-12 | 2025-10-01 | 4 | 0001193125-25-276344 | View SEC Doc Filr Page |
| 4 | 2025-11-12 | 2025-10-01 | 4 | 0001193125-25-276340 | View SEC Doc Filr Page |
| 4 | 2025-11-12 | 2025-10-01 | 4 | 0001193125-25-276336 | View SEC Doc Filr Page |
| 4 | 2025-11-12 | 2025-10-01 | 4 | 0001193125-25-276325 | View SEC Doc Filr Page |
| 8-K/A | 2025-10-15 | 2025-06-24 | FORM 8-K/A | 0001171843-25-006441 | View SEC Doc Filr Page |
| 8-K | 2025-10-03 | 2025-10-01 | FORM 8-K | 0001171843-25-006266 | View SEC Doc Filr Page |
| 3 | 2025-09-30 | 2025-08-29 | 3 | 0001193125-25-224356 | View SEC Doc Filr Page |
| 3 | 2025-09-30 | 2025-08-29 | 3 | 0001193125-25-224253 | View SEC Doc Filr Page |
| 3 | 2025-09-29 | 2025-08-29 | 3 | 0001193125-25-222032 | View SEC Doc Filr Page |
| 3 | 2025-09-16 | 2025-08-29 | 3 | 0001193125-25-204668 | View SEC Doc Filr Page |
| 8-K | 2025-09-02 | 2025-08-29 | FORM 8-K | 0001171843-25-005673 | View SEC Doc Filr Page |
| 10-Q | 2025-08-13 | 2025-06-30 | FORM 10-Q | 0001171843-25-005368 | View SEC Doc Filr Page |
| ARS | 2025-07-07 | 2024-12-31 | ARS | 0001193125-25-156279 | View SEC Doc Filr Page |
| DEF 14A | 2025-07-07 | 2025-08-29 | DEF 14A | 0001193125-25-156276 | View SEC Doc Filr Page |